Aziza E Abdelrahman
Overview
Explore the profile of Aziza E Abdelrahman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ibrahim H, Abdelrahman A, Elwan A, Gharieb S, Refaat M, Elmesallamy W, et al.
Appl Immunohistochem Mol Morphol
. 2024 Jun;
32(6):292-304.
PMID: 38863278
Objectives: To find predictive biomarkers for recurrence and progression of meningioma. Background: Despite great advances in meningioma treatment, the prognosis remained unfavorable due to the high recurrence rate. Methods: In...
2.
Abdullatif A, Abdelrahman A, Bakry A, Gharieb S, Ramadan M, Wasfy M, et al.
Contemp Oncol (Pozn)
. 2024 May;
28(1):51-62.
PMID: 38800530
Introduction: Death in cervical cancer patients is usually due to invasion and metastasis due to the aggressive nature of the tumour. Therefore, it is critical to identify potent therapeutic targets...
3.
Ibrahim H, Abdelrahman A, Elsebai E, Gharieb S, Fahmy M, Ramadan M, et al.
Asian Pac J Cancer Prev
. 2023 Sep;
24(9):3247-3259.
PMID: 37774079
Objectives: Serous ovarian carcinoma (SOC) is a biologically heterogeneous with different genomic and molecular profiles, beside clinical response to the chemotherapy with subsequent in obstacles in starting unified, acceptable treatments...
4.
Ibrahim H, Abdelrahman A, Elwan A, Bakry A, Fahmy M, Abdelhamid M, et al.
Appl Immunohistochem Mol Morphol
. 2023 Sep;
31(10):673-681.
PMID: 37751246
There is a cellular crosstalk between Wnt/β-catenin and Hippo/Yes-related protein 1 signaling paths in colon cancer (CC) which promotes EMT processes that mediate the metastatic progression of CC. We aimed...
5.
Mosaad H, Abdelrahman A, Abdullatif A, Lashin M, Ramadan M, El-Azony A, et al.
Asian Pac J Cancer Prev
. 2023 Jan;
24(1):239-248.
PMID: 36708573
Objective: To asses miR-379-5p expression in endometrial cancer (EC) and its correlation with ROR1 expression and to investigate the relation between miR-379-5p and ROR1 expressions and the clinicopathological picture of...
6.
Abdelrahman A, Salem A, Al Attar A, Elsebai E, Samy W, Ibrahim M, et al.
Appl Immunohistochem Mol Morphol
. 2022 Oct;
30(10):713-725.
PMID: 36251972
Endometrial cancer (EC) is the most common gynecologic cancer and the current methods for the prediction of its prognosis and treatment response are unfortunately suboptimal. In this study, we evaluated...
7.
Ibrahim D, Elsebai E, Fayed A, Abdelrahman A
Indian J Pathol Microbiol
. 2022 Apr;
65(2):328-335.
PMID: 35435367
Background: NOTCH1 pathway activation has been recently described to be a key player in gastric carcinogenesis, enhance the survival and proliferation of cancer stem cells (CSCs) and mediate chemoresistance in...
8.
Abdelrahman A, El-Azony A, Elsebai E, Ibrahim H
Appl Immunohistochem Mol Morphol
. 2021 Oct;
30(2):126-135.
PMID: 34657081
The potentiation and activation of Wnt signaling pathways are now assumed to mediate the self-renewal and proliferation of colon cancer stem cells that are responsible for therapeutic resistance, tumor relapse,...
9.
Elwan A, Abdelrahman A, Alnagar A, Abdelhamid M, Nawar N
Turk Patoloji Derg
. 2021 Jan;
37(2):121-129.
PMID: 33432555
Objective: As the genetic and molecular profiles of triple negative breast carcinoma (TNBC) are elucidated, multiple therapeutic targets have been produced. TNBC with less than 1% androgen receptor (AR) expression...
10.
Abdelrahman A, Rashed H, MostafaToam , Omar A, Abdelhamid M, Matar I
Ann Diagn Pathol
. 2020 Dec;
51:151676.
PMID: 33360026
Patients with breast cancer are appropriate candidates for neoadjuvant chemotherapy (NAC) to facilitate conservative surgery. The chemotherapeutic agents may exert their action by inducing the anti-tumor immune response. This study...